Tech Company Financing Transactions
Octopath AI Funding Round
Twin Path Ventures and Innovate UK participated in a $2 million Seed funding round for Octopath AI. The funding round was announced by the company on 11/3/2026.
Transaction Overview
Company Name
Announced On
11/3/2026
Transaction Type
Venture Equity
Amount
$1,950,000
Round
Seed
Investors
Twin Path Ventures (Lead Investor)
Proceeds Purpose
Octopath AI will use the funding to advance the clinical evaluation, product development and regulatory approval of its AI-powered cancer pathology diagnostic platform. The investment will support the development and validation of its foundation models, Kraken and Nemo, which analyse tissue slides at single-cell resolution to help pathologists identify cancer-related cellular information more efficiently. The company will also use the capital to strengthen its technology, conduct clinical evaluations and complete the regulatory work required to secure approval for its diagnostic platform.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
Undisclosed
London, Undisclosed
UK
London, Undisclosed
UK
Phone
Undisclosed
Website
Email Address
Overview
Octopath AI is a medical technology startup and spinout from University College London (UCL) Department of Medical Physics and Biomedical Engineering. It develops advanced artificial intelligence foundation models and tools (such as Kraken for cell classification and Nemo for immunohistochemistry analysis) for digital pathology, tissue slide analysis, and precision cancer diagnostics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Esther Baer
Co-Founder
Charles-Antoine Collins-Fekete
Browse more venture capital transactions:
Prev: 11/3/2026: Clark Technologies venture capital transaction
Next: 11/3/2026: Cephable venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs